Biochemical findings in common inborn errors of metabolism

被引:34
作者
Pasquali, M
Monsen, G
Richardson, L
Alston, M
Longo, N
机构
[1] ARUP Labs, Biochem Genet & Newborn Screening Labs, Salt Lake City, UT 84108 USA
[2] Univ Utah, Metab Serv, Salt Lake City, UT 84112 USA
[3] ARUP Labs, Biochem Genet Sect, Salt Lake City, UT 84108 USA
[4] ARUP Labs, Supplemental Newborn Screening Lab, Salt Lake City, UT 84108 USA
关键词
newborn screening; tandem mass spectrometry; organic acidemias; urine acylglycine; urine acylcarnitine;
D O I
10.1002/ajmg.c.30086
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The application of tandem mass spectrometry (MS/MS) to newborn screening has led to the detection of patients with a wider spectrum of inborn errors of metabolism. A definitive diagnosis can often be established early enough to start treatment before symptoms appear. Here, we review common biochemical findings in disorders caused by deficiency of 3-methylcrotonyl-CoA carboxylase, isobutyryl-CoA dehydrogenase, 2-methyl-3-hydroxybutyryl-CoA dehydrogenase, 3-ketothiolase, 2-methylbutyryl-CoA dehydrogenase, and medium chain acyl CoA dehydrogenase. The diagnosis of these disorders requires biochemical confirmation by measurement of plasma acylcarnitine profile, urine organic acids, and urine acylglycine profiles followed by measurement of enzyme activity or detection of causative mutations. Early treatment can improve the outcome of these disorders. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:64 / 76
页数:13
相关论文
共 49 条
[1]   Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: Identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism [J].
Andresen, BS ;
Christensen, E ;
Corydon, TJ ;
Bross, P ;
Pilgaard, B ;
Wanders, RJA ;
Ruiter, JPN ;
Simonsen, H ;
Winter, V ;
Knudsen, I ;
Schroeder, LD ;
Gregersen, N ;
Skovby, F .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (05) :1095-1103
[2]   The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: Is there correlation between genotype and phenotype? [J].
Andresen, BS ;
Bross, P ;
Udvari, S ;
Kirk, J ;
Gray, G ;
Kmoch, S ;
Chamoles, N ;
Knudsen, I ;
Winter, V ;
Wilcken, B ;
Yokota, I ;
Hart, K ;
Packman, S ;
Harpey, JP ;
Saudubray, JM ;
Hale, DE ;
Bolund, L ;
Kolvraa, S ;
Gregersen, N .
HUMAN MOLECULAR GENETICS, 1997, 6 (05) :695-707
[3]   Medium-chain Acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-Based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency [J].
Andresen, BS ;
Dobrowolski, SF ;
O'Reilly, L ;
Muenzer, J ;
McCandless, SE ;
Frazier, DM ;
Udvari, S ;
Bross, P ;
Knudsen, I ;
Banas, R ;
Chace, DH ;
Engel, P ;
Naylor, EW ;
Gregersen, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) :1408-1418
[4]   ISOLATED BIOTIN-RESISTANT DEFICIENCY OF 3-METHYLCROTONYL-COA CARBOXYLASE PRESENTING AS A CLINICALLY SEVERE FORM IN A NEWBORN WITH FATAL OUTCOME [J].
BANNWART, C ;
WERMUTH, B ;
BAUMGARTNER, R ;
SUORMALA, T ;
WIESMANN, UN .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (06) :863-868
[5]   ISOLATED BIOTIN-RESISTANT 3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY PRESENTING WITH LIFE-THREATENING HYPOGLYCEMIA [J].
BARTLETT, K ;
BENNETT, MJ ;
HILL, RP ;
LASHFORD, LS ;
POLLITT, RJ ;
WORTH, HGJ .
JOURNAL OF INHERITED METABOLIC DISEASE, 1984, 7 (04) :182-182
[6]   The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency [J].
Baumgartner, MR ;
Almashanu, S ;
Suormala, T ;
Obie, C ;
Cole, RN ;
Packman, S ;
Baumgartner, ER ;
Valle, D .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04) :495-504
[7]   Consanguineous 3-methylcrotonyl-CoA carboxylase deficiency: Early-onset necrotizing encephalopathy with lethal outcome [J].
Baykal, T ;
Gokcay, GH ;
Ince, Z ;
Dantas, MF ;
Fowler, B ;
Baumgartner, MR ;
Demir, F ;
Can, G ;
Demirkol, M .
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (02) :229-233
[8]   Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies [J].
Carpenter, K ;
Wiley, V ;
Sim, KG ;
Heath, D ;
Wilcken, B .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2001, 85 (02) :F105-F109
[9]  
Dantas Maria Fernanda, 2005, Hum Mutat, V26, P164, DOI 10.1002/humu.9352
[10]   Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency [J].
Ensenauer, R ;
Niederhoff, H ;
Ruiter, JPN ;
Wanders, RJA ;
Schwab, KO ;
Brandis, M ;
Lehnert, W .
ANNALS OF NEUROLOGY, 2002, 51 (05) :656-659